SCHEMBL6976007

SCHEMBL6976007

COc1cccc(C=CC2CCCCC(=O)N2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
CASP3 P42574 1/20 0.48
RAB9A P51151 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
RELA Q04206 1/20 0.43
EGFR P00533 1/20 0.43
FBP1 P09467 1/20 0.42
NFE2L2 Q16236 2/20 0.42
ALOX5 P09917 1/20 0.41
CYP19A1 P11511 1/20 0.41
NQO2 P16083 1/20 0.41
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
PIM1 P11309 1/20 0.41
AKR1B1 P15121 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
HSP90AA1 P07900 1/20 0.41
CCR6 P51684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976012 1.00 NPC1 (0.48) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL6976002 1.00 NPC1 (0.48) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL6964888 0.88 NPC1 (0.46) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL6964891 0.88 NPC1 (0.46) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL6690505 0.82 RELA (0.50) NPC1RAB9ARELAFBP1NFE2L2
SCHEMBL6690502 0.82 RELA (0.50) NPC1RAB9ARELAFBP1NFE2L2
SCHEMBL6690511 0.82 RELA (0.50) NPC1RAB9ARELAFBP1NFE2L2
SCHEMBL5413534 0.80 LMNA (0.39) RAB9AHSP90AA1
SCHEMBL10766334 0.80 RELA (0.46) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL8143525 0.79 CYP4F2 (0.40) NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
US-5883251-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 1999-03-16 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed